Clinical efficacy of montelukast sodium combined with budesonide or combined with loratadine in treating children with cough variant asthma and influence on inflammatory factors in the serum.

In conclusion, the method of montelukast sodium combined with budesonide or loratadine are both worthy of clinical promotion because they have equivalent efficacy in the treatment of cough variant asthma to effectively improve the lung function and inflammatory response in patients and both bring less adverse reactions and lower recurrence rate. PMID: 31258680 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31258680?dopt=Abstract

Source: Experimental and Therapeutic Medicine - July 3, 2019 Category: General Medicine Tags: Exp Ther Med Source Type: research